Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10459.1/46370

A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts
Ribas i Fortuny, Judit; Ni, Xiaohua; Castanares, Mark; Liu, Minzhi M.; Esopi, David; Yegnasubramanian, Srinivasan; Rodriguez, Ronald; Mendell, Joshua T.; Lupold, Shawn E.
miR-21 is the most commonly over-expressed microRNA (miRNA) in cancer and a proven oncogene. Hsa-miR-21 is located on chromosome 17q23.2, immediately downstream of the vacuole membrane protein-1 (VMP1) gene, also known as TMEM49. VMP1 transcripts initiate ∼130 kb upstream of miR-21, are spliced, and polyadenylated only a few hundred base pairs upstream of the miR-21 hairpin. On the other hand, primary miR-21 transcripts (pri-miR-21) originate within the last introns of VMP1, but bypass VMP1 polyadenylation signals to include the miR-21 hairpin. Here, we report that VMP1 transcripts can also bypass these polyadenylation signals to include miR-21, thus providing a novel and independently regulated source of miR-21, termed VMP1–miR-21. Northern blotting, gene-specific RT-PCR, RNA pull-down and DNA branching assays support that VMP1–miR-21 is expressed at significant levels in a number of cancer cell lines and that it is processed by the Microprocessor complex to produce mature miR-21. VMP1 and pri-miR-21 are induced by common stimuli, such as phorbol-12-myristate-13-acetate (PMA) and androgens, but show differential responses to some stimuli such as epigenetic modifying agents. Collectively, these results indicate that miR-21 is a unique miRNA capable of being regulated by alternative polyadenylation and two independent gene promoters. The ‘National Institutes of Health/National Cancer Institute’ [5R01CA143299 to S.E.L., 5P50CA058236 to S.E.L. (Project 1)]; Department of Defense Prostate Cancer Research Fund [W81XWH-08-13-5 to S.E.L.]; Patrick C. Walsh Prostate Cancer Research Fund (to S.E.L.); Spanish ‘Ministerio de Ciencia e Innovación’ [SAF2011-29730 to J.R.]. Funding for open access charge: National Institutes of Health/NCI R01CA143299.
-miR-21
-RNA
-Càncer
-Gens
-ADN
-Cicle cel·lular
cc-by-nc, (c) Ribas et al., 2012
http://creativecommons.org/licenses/by-nc/3.0/es/deed.ca
article
publishedVersion
Oxford University Press
         

Documentos con el texto completo de este documento

Ficheros Tamaño Formato Vista
017838.pdf 2.118 MB application/pdf Vista/Abrir

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a